2009
DOI: 10.1111/j.1742-4658.2009.06922.x
|View full text |Cite
|
Sign up to set email alerts
|

Functional analysis of mutations in UDP‐galactose‐4‐epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE‐null cells

Abstract: Galactosemia is caused by defects in the galactose metabolic pathway, which consists of three enzymes, including UDP‐galactose‐4‐epimerase (GALE). We previously reported nine mutations in Korean patients with epimerase‐deficiency galactosemia. In order to determine the functional consequences of these mutations, we expressed wild‐type and mutant GALE proteins in 293T cells. GALEE165K and GALEW336X proteins were unstable, had reduced half‐life, formed aggregates and were partly degraded by the proteasome comple… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
17
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 32 publications
1
17
0
Order By: Relevance
“…A relevant example concerns the in vivo GALE aggregation in type III galactosemia (Bang et al. 2009). Accordingly, the results from the structural analyses of the GALT mutants herein characterized strongly suggest that GALT aggregation associated with protein misfolding might be a major pathogenic mechanism in classic galactosemia, setting the basis for future studies on in vivo GALT aggregation.…”
Section: Discussionmentioning
confidence: 99%
“…A relevant example concerns the in vivo GALE aggregation in type III galactosemia (Bang et al. 2009). Accordingly, the results from the structural analyses of the GALT mutants herein characterized strongly suggest that GALT aggregation associated with protein misfolding might be a major pathogenic mechanism in classic galactosemia, setting the basis for future studies on in vivo GALT aggregation.…”
Section: Discussionmentioning
confidence: 99%
“…More than 20 different, ostensibly causal genetic variants have been identified in the GALE loci of patients with biochemically confirmed epimerase deficiency; a subset of these alleles and the GALE proteins they encode have been studied in vitro and/or in vivo, revealing a range of degrees and mechanisms of impairment (Alano et al 1998;Bang et al 2009;Chhay et al 2008b;Henderson et al 2001;Maceratesi et al 1996Maceratesi et al , 1998Openo et al 2006;Park et al 2005;Quimby et al 1997;Thoden et al 2001b;Timson 2005;Wohlers and Fridovich-Keil 2000;Wohlers et al 1999). Some variant GALE proteins are catalytically impaired, while others demonstrate compromised stability, at least under defined laboratory conditions.…”
Section: Introductionmentioning
confidence: 99%
“…Another identified protein named UDP-galactose 4-epimerase (GALE) was also down-reg- ulated in thiram treated chondrocytes. GALE protein is an enzyme responsible for the epimerization of UDP-glucose and UDP-N-acetyl glucosamine to UDP-galactose, and UDP-N-acetyl galactosamine, and vice versa (Niou et al, 2009;Bang et al, 2009). GALE plays crucial role in energy metabolism through production of UDP-glucose and UDP-N-acetyl glucosamine necessary for mucopolysaccharide, glycoprotein, glycolipid, and the proteoglycan biosynthesis (Sweeney et al, 1993;Lai et al, 2009).…”
Section: Discussionmentioning
confidence: 99%